: We conclude that treatment of triple negative breast cancers with growth hormone - releasing hormone
antagonists reduces tumor growth and potentiates the effects of cytotoxic therapy by nullifying drug resistance.
Not exact matches
These results illustrate the ability of GHRH
antagonists to not only inhibit the
growth of
tumors, but also to enhance the effectiveness of other drugs by
reducing resistance.